Cardiovascular Disease News and Research RSS Feed - Cardiovascular Disease News and Research

According to the Centers for Disease Control and Prevention, about 700,000 people die annually of cardiovascular disease. Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself. There are well known environmental risk factors associated with cardiovascular disease such as smoking, diet, inactivity and increased alcohol use. Heredity also plays a factor in cardiovascular disease since other risk factors like high blood pressure and high LDL cholesterol tend to run in families. Cardiovascular disease can be reduced by controlling environmental factors and understanding the genetic factors that put people at greater risk for heart disease.
Obese people experience silent cardiac damage that fuels risk for heart failure

Obese people experience silent cardiac damage that fuels risk for heart failure

Using an ultrasensitive blood test to detect the presence of a protein that heralds heart muscle injury, researchers from Johns Hopkins and elsewhere have found that obese people without overt heart disease experience silent cardiac damage that fuels their risk for heart failure down the road. [More]
Cocaine disrupts woman's estrus cycle, may explain sex differences in cocaine addiction

Cocaine disrupts woman's estrus cycle, may explain sex differences in cocaine addiction

Women are more sensitive to the effects of cocaine and more susceptible to cocaine abuse than men. Cocaine's ability to disrupt a woman's estrus cycle may explain the sex differences in cocaine addiction, and new evidence that caffeine may be neuroprotective and able to block cocaine's direct effects on the estrus cycle reveals novel treatment possibilities, according to an article published in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Coqui Pharma signs contract with INVAP to design Medical Isotope Production Facility in Alachua, Fla

Coqui Pharma signs contract with INVAP to design Medical Isotope Production Facility in Alachua, Fla

Coqui RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide. [More]
CHOP presents new findings on pediatric cardiovascular disease at AHA Scientific Sessions

CHOP presents new findings on pediatric cardiovascular disease at AHA Scientific Sessions

Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2014 in Chicago. [More]
Changes in one gene can influence person's cholesterol levels from midlife through late life

Changes in one gene can influence person's cholesterol levels from midlife through late life

It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life. [More]
Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen announces submission of NDA for three-month paliperidone palmitate

Janssen Research & Development, LLC today announced the submission of a New Drug Application (NDA) for three-month atypical antipsychotic paliperidone palmitate to the U.S. Food and Drug Administration. The NDA seeks approval for the medication as a treatment for schizophrenia in adults. [More]
Cholesterol efflux appears to be superior indicator of cardiovascular risk

Cholesterol efflux appears to be superior indicator of cardiovascular risk

Groundbreaking research from UT Southwestern Medical Center shows that cholesterol efflux capacity (cholesterol efflux), which measures HDL cholesterol function, appears to be a superior indicator of cardiovascular risk and a better target for therapeutic treatments than standard measurements of HDL. Current measurement methods reflect only the circulating levels of HDL and not the functional properties of this lipoprotein. [More]
Nationwide STEMI rates drop, reveals Vanderbilt study

Nationwide STEMI rates drop, reveals Vanderbilt study

The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments' quality and timeliness of care. [More]
Omega-3 fatty acids decrease risk of getting heart disease

Omega-3 fatty acids decrease risk of getting heart disease

Increasing the amount of omega-3s in your diet, whether from fish or flax, will likely decrease your risk of getting heart disease, according to Penn State nutritionists. [More]
TapImmune signs new collaborative research agreement with VGTI Florida

TapImmune signs new collaborative research agreement with VGTI Florida

TapImmune, Inc., is pleased to announce a new collaborative research agreement with The Vaccine & Gene Therapy Institute of Florida, a leading, non-profit biomedical research institute, forming a partnership to advance TapImmune's proprietary, cancer vaccines into Phase II human clinical trials for the treatment of breast and ovarian cancers. [More]
Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

Researchers from Allina Health and the Minneapolis Heart Institute Foundation have presented on the results and implications of The Heart of New Ulm Project on heart disease risk factors at the American Heart Association Scientific Sessions in Chicago, Ill. [More]
Scientists identify defects in colossal heart protein which leads to stroke, heart failure

Scientists identify defects in colossal heart protein which leads to stroke, heart failure

The landmark discovery of a tiny defect in a vital heart protein has for the first time enabled heart specialists to accurately pinpoint a therapeutic target for future efforts in developing a drug-based cure for cardiovascular diseases. [More]
Asthma associated with higher risk of heart attack or stroke

Asthma associated with higher risk of heart attack or stroke

Asthma that requires daily medication is associated with a significantly higher risk of heart attack or stroke, according to a new study from the University of Wisconsin School of Medicine and Public Health. [More]
Vital exhaustion may increase risk of first-time cardiovascular disease by 36%

Vital exhaustion may increase risk of first-time cardiovascular disease by 36%

Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman's risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association's Scientific Sessions 2014 in Chicago, IL. [More]
Chemical compound in coffee may help prevent damaging effects of obesity

Chemical compound in coffee may help prevent damaging effects of obesity

Researchers at the University of Georgia have discovered that a chemical compound commonly found in coffee may help prevent some of the damaging effects of obesity. [More]
DaVita Kidney Care, Medtronic partner to better understand cardiovascular health in ESRD patients

DaVita Kidney Care, Medtronic partner to better understand cardiovascular health in ESRD patients

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and leading provider of kidney care services, announced today a collaboration with Medtronic, Inc., to better understand cardiovascular health in end stage renal disease (ESRD) patients. [More]
Experts focus on key issues impeding delivery of cardiac care in resource-limited settings

Experts focus on key issues impeding delivery of cardiac care in resource-limited settings

Critical care is defined by life-threatening conditions, which require close evaluation, monitoring, and treatment by appropriately trained health professionals. Cardiovascular care bears these same requirements. [More]
Sleep disorders increase risk of motor vehicle accidents, poor health status among firefighters

Sleep disorders increase risk of motor vehicle accidents, poor health status among firefighters

Sleep disorders are independent risk factors for heart attacks and motor vehicle crashes, which are the two leading causes of death for firefighters in the United States. [More]
Isis Pharmaceuticals, AstraZeneca partner to develop new delivery methods for antisense oligonucleotides

Isis Pharmaceuticals, AstraZeneca partner to develop new delivery methods for antisense oligonucleotides

AstraZeneca and Isis Pharmaceuticals Inc. today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. [More]
Metabolic syndrome screening in bipolar disorder warranted

Metabolic syndrome screening in bipolar disorder warranted

The frequency of the metabolic syndrome in patients with bipolar disorder warrants systematic screening, say researchers, particularly among men, older patients and those receiving atypical antipsychotic treatment. [More]